You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Intuniv

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Drug Use Study With Intuniv® in European Countries

Active, not recruiting
  • Attention Deficit Hyperactivity Disorder (ADHD)
  • No Intervention
  • Munich, Bavaria, Germany
    Real World Insights EMEA IQVIA Commercial GmbH & Co. OHG
May 12, 2023

ADHD Trial in New York (Guanfacine, Lisdexamfetamine)

Terminated
Has Results
  • Attention Deficit Hyperactivity Disorder
  • New York, New York
    New York State Psychiatric Institute
Jan 18, 2023

Drug Use Study With Intuniv® in Australia

Completed
  • Attention Deficit Hyperactivity Disorder (ADHD)
    • Sydney, New South Wales, Australia
      Site
    Sep 27, 2021

    Cannabis Use Disorder Trial in Parkville (Guanfacine Extended Release Oral Tablet, Residential withdrawal, Engagement with

    Not yet recruiting
    • Cannabis Use Disorder
    • Guanfacine Extended Release Oral Tablet
    • +3 more
    • Parkville, Victoria, Australia
      Orygen
    Jul 16, 2023

    Chronic Pain Trial in Boston (Morphine, Guanfacine 1mg, Guanfacine 2mg)

    Active, not recruiting
    • Chronic Pain
    • Boston, Massachusetts
      Center for Translational Pain Research
    Apr 4, 2022

    Tourette Disorder, Tourette Syndrome Trial in New Haven, Tampa, New York (, extended-release guanfacine (Intuniv))

    Completed
    Has Results
    • Tourette Disorder
    • Tourette Syndrome
    • placebo
    • extended-release guanfacine (Intuniv)
    • New Haven, Connecticut
    • +2 more
    Aug 11, 2021

    Cannabis Use Trial in New York (guanfacine-ER, Placebo)

    Recruiting
    • Cannabis Use
    • New York, New York
      STARS Clinic at Columbia and NYSPI Department of Psychiatry
    Jun 6, 2022

    Smoking Cessation Trial in New Haven (Varenicline, Guanfacine ER)

    Recruiting
    • Smoking Cessation
    • New Haven, Connecticut
      Yale University
    Jan 31, 2022

    ADHD Trial in London (Lisdexamfetamine dimesylate, Guanfacine Extended Release Oral Tablet, Placebo)

    Active, not recruiting
    • ADHD
    • Lisdexamfetamine dimesylate
    • +2 more
    • London, United Kingdom
      Institute of Psychiatry, Psychology & Neuroscience; King's Colle
    Aug 16, 2022

    Chronic Pain Trial in Boston (Guanfacine, Placebo)

    Active, not recruiting
    • Chronic Pain
    • Boston, Massachusetts
      MGH Center for Translational Pain Research
    Apr 4, 2022

    Smoking Cessation Trial in New Haven (Guanfacine, Placebo)

    Completed
    Has Results
    • Smoking Cessation
    • New Haven, Connecticut
      Yale Center for Clinical Investigations, Yale University
    Nov 30, 2021

    Alcohol Use Trial in New Haven (Guanfacine ER, Placebo)

    Recruiting
    • Alcohol Use
    • Guanfacine ER
    • Placebo
    • New Haven, Connecticut
      Yale University School of Medicine
    Mar 11, 2022

    Prader-Willi Syndrome, Aggression, Self-Injurious Behavior Trial in Brooklyn (Guanfacine Extended Release, Placebo)

    Recruiting
    • Prader-Willi Syndrome
    • +20 more
    • Guanfacine Extended Release
    • Placebo
    • Brooklyn, New York
      Maimonides Medical Center
    Dec 20, 2022

    Stress Disorder Trial in Farmington (Guanfacine Extended Release, Mindfulness Skills Therapy, Placebo)

    Withdrawn
    • Stress Disorder
    • Guanfacine Extended Release
    • +2 more
    • Farmington, Connecticut
      UConn Health
    Mar 4, 2021

    Attention Deficit Disorder With Hyperactivity (ADHD) Trial in Stockholm (methylphenidate medication, atomoxetine medication,

    Active, not recruiting
    • Attention Deficit Disorder With Hyperactivity (ADHD)
    • methylphenidate medication
    • +3 more
    • Stockholm, Stockholm County, Sweden
      Division for Child and Adolescent Psychiatry in Stockholm
    Oct 7, 2021

    Healthy Trial in Hackensack (SPD503, Concerta, SPD503 + Concerta)

    Completed
    Has Results
    • Healthy
    • Hackensack, New Jersey
      Advanced Biomedical Research, Inc.
    Jun 10, 2021

    Smoking Trial in New Haven (Guanfacine)

    Completed
    Has Results
    • Smoking
    • New Haven, Connecticut
      Yale Center for Clinical Investigations, Yale University
    Mar 4, 2020

    Pervasive Development Disorders Trial in United States (, extended-release guanfacine)

    Completed
    Has Results
    • Pervasive Development Disorders
    • placebo
    • extended-release guanfacine
    • Los Angeles, California
    • +4 more
    Mar 18, 2020

    ADHD (ADHD) Trial in Worldwide (Extended-release Guanfacine HCl (Intuniv, SPD503))

    Completed
    Has Results
    • Attention Deficit Hyperactivity Disorder (ADHD)
    • Extended-release Guanfacine HCl (Intuniv, SPD503)
    • Graz, Austria
    • +59 more
    May 26, 2021

    Attention-Deficit/Hyperactivity Disorder Trial in Canada, United States (extended-release guanfacine HCl (SPD503), ,

    Completed
    Has Results
    • Attention-Deficit/Hyperactivity Disorder
    • extended-release guanfacine hydrochloride (SPD503)
    • +2 more
    • Little Rock, Arkansas
    • +45 more
    May 14, 2021

    ADHD Trial in Worldwide (Guanfacine HCl (TAK-503), Atomoxetine HCl, Placebo)

    Recruiting
    • Attention Deficit Hyperactivity Disorder
    • Guanfacine hydrochloride (TAK-503)
    • +2 more
    • Dothan, Alabama
    • +42 more
    Aug 19, 2022

    ADHD Trial in United States (SPD503-AM, SPD503-PM, Placebo)

    Completed
    Has Results
    • ADHD
    • Dothan, Alabama
    • +60 more
    Jun 10, 2021

    Attention-Deficit/Hyperactivity Disorder Trial in United States (Extended-release Guanfacine Hydrochloride, Placebo)

    Completed
    Has Results
    • Attention-Deficit/Hyperactivity Disorder
    • Extended-release Guanfacine Hydrochloride
    • Placebo
    • Dothan, Alabama
    • +53 more
    Jun 25, 2021

    ADHD Trial in Worldwide (Extended-release Guanfacine Hydrochloride, Atomoxetine Hydrochloride, Placebo Comparator)

    Completed
    Has Results
    • Attention Deficit Hyperactivity Disorder
    • Extended-release Guanfacine Hydrochloride
    • +2 more
    • San Diego, California
    • +65 more
    Jun 10, 2021

    Cannabis Dependence Trial in New York (Guanfacine)

    Completed
    Has Results
    • Cannabis Dependence
    • New York, New York
      STARS
    Jan 17, 2019